Cannigistics Enters into MOU for Clinical Trials Software Platform
Cannigistics Enters into Memorandum
of Understanding for Clinical Trials Software Platform
March 16, 2015 – Vancouver, British Columbia – Calyx Bio-Ventures Inc. (TSXV:CYX) (“Calyx” or
“the Company”) is pleased to announce that its wholly-owned subsidiary, Cannigistics Agri-Solutions
Corp. (“Cannigistics”), has entered into a memorandum of understanding (“MOU”) with a third party
with respect to the implementation of a clinical trials software platform.
The MOU has been signed with a well respected group of Canadian medical specialists that require a
secure platform to gather, store, analyze, and report on the results of the trials. The Cannigistics’ software
and information technology platform will be utilized to create an environment that will allow the
physicians to conduct the trials with confidence. Data can be used, parsed, sorted, analyzed and made
anonymous so that other specialists can also have access to the results with no concerns over patient
confidentiality.
The resulting platform will be a tailor made solution licensed on a non-exclusive basis, allowing
Cannigistics to license the resulting platform to any other parties conducting clinical trials with the ability
to customize to their specific needs. This will be a new area of deployment for the Cannigistics software
platform, and potentially opens up a new market in the near term.
“We are pleased to have entered into an agreement with a respected group of healthcare practitioners to
provide an end-to-end technical solution, from application design to deployment and management” said
Roger Forde, President and CEO of Cannigistics. “This further validates the strategy that Cannigistics
has established to provide technology solutions addressing key requirements of companies operating in
the health sciences sector. We are looking forward to becoming a significant participant in the sector.”
About Calyx
Calyx’s wholly-owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company
that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software
platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and
positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with
advanced controls over all aspects of their operations. Additionally, Calyx owns a portfolio of proprietary
intellectual property with applications in crop enhancement. Calyx also has an approximate shareholding
of 19% in Agrisoma Biosciences Inc., a company which is commercializing carinata, a non-food energy
feedstock crop, for biofuel production.
For further information about Calyx, please visit www.calyxbio.com or contact:
Don Konantz
President & CEO
Calyx Bio-Ventures Inc.
Tel: 604-649-5961
Email: dkonantz@calyxbio.comFor additional information about Cannigistics, please visit www.cannigistics.com or contact:
Roger Forde
President & CEO
Cannigistics Agri-Solutions Corp.
Tel: 778-331-5156
Email: roger@cannigistics.com
